- Home
- MRNA vs CFG Comparison
MRNA vs CFG Comparison
Compare MRNA & CFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | CFG |
|---|---|---|
| Founded | 2010 | 1828 |
| Country | United States | United States |
| Employees | N/A | 17398 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 27.1B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | CFG |
|---|---|---|
| Price | $51.65 | $65.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 20 |
| Target Price | $34.27 | ★ $66.85 |
| AVG Volume (30 Days) | ★ 5.3M | 3.9M |
| Earning Date | 04-30-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $8.74 | $20.15 |
| Revenue Next Year | $16.18 | $8.19 |
| P/E Ratio | ★ N/A | $16.85 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $33.95 |
| 52 Week High | $59.55 | $68.79 |
Technical Indicators
Market Signals| Indicator | MRNA | CFG |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 70.21 |
| Support Level | $47.61 | $58.58 |
| Resistance Level | $54.94 | $65.88 |
| Average True Range (ATR) | 2.50 | 1.34 |
| MACD | -0.23 | 0.90 |
| Stochastic Oscillator | 60.01 | 99.78 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CFG Citizens Financial Group Inc.
Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through its subsidiaries, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The group's reportable business segments are: Consumer Banking and Commercial Banking. The majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services, including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management solutions, among others, through a network of branches and ATMs.